IL-7 fusion proteins
US7960514B2 · kind B2 · utility
6Cited by
72References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2007 |
| Grant date | Jun 14, 2011 |
| Priority date | — |
| Expiry date | May 17, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a fusion protein which includes a first portion including an immunoglobulin (Ig) chain and a second portion including interleukin-7 (IL-7).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.